drugset / Trial / NCT03460041
Caudal Dexmetedomedine Versus Magnesium in Orthopedic Pediatric Surgeries
RandomizedParallel-groupTriple-blindPrevention
Summary
This study will be performed in Abo Elreesh Pediatric Hospital / Cairo University after obtaining approval by the University Ethics Committee, and a written informed consent from the parents or guardians. Thirty six patients will be randomly assigned using an online randomization program (http://www.randomizer.org) and the sealed envelope method into three groups: Group D (n=12): Dexmetedomidine group. 0.5 ml of dexmetedomidine (2 μg/kg) added to bupivacaine, Group M (n=12) : Magnesium group.0.5 ml of magnesium sulphate (50 mg) added to bupivacaine, Group C (n=12) :Control group.bupivacaine 0.25% diluted in normal saline with total volume of 1 ml/kg.
Timeline
- Start
- 2017-12-01
- Primary completion
- 2018-03-15
- Completion
- 2018-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmetedomedine | Unknown | 2 ug/kg | Other |
| Comparator | Magnesium Sulfate | Other / unclassified | 50 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
Indications
No indication recorded.